ad

Paras Healthcare IPO Day 2: Subscription Status on 22 October 2026

Paras Healthcare IPO Day 2, 22 Oct 2026. Subscribed 0.15x on Day 1: Retail 0.73x, NII 0.08x, QIB 0.00x. Price band Rs 660-693. Lot size 21 shares.


21 Oct 2026 • 11:47 pm

Paras Healthcare IPO Day 2: Subscription Status on 22 October 2026

Quick Answer

The Paras Healthcare IPO is on Day 2 of bidding on 22 October 2026. The issue was subscribed 0.15 times at the Day 1 reading on 21 October, with retail at 0.73 times, NII at 0.08 times and QIB at 0.00 times excluding the anchor portion. Bidding remains open until 23 October 2026, and investors should track the live category wise numbers on BSE and NSE through the day.

Paras Healthcare Limited, a North India hospital chain, is on Day 2 of its IPO bidding window, which opened on 21 October 2026 and closes on 23 October 2026. The Paras Healthcare IPO is a mainboard, book built issue worth about Rs 1,450 crore, with a Rs 500 crore fresh issue and an offer for sale of about Rs 950 crore, and the shares are proposed to list on BSE and NSE.

Bids on Day 1 were for about 17.83 lakh shares against roughly 1.15 crore shares on offer to the public, from about 50,867 applications. Retail led the early bidding, while institutional and non-institutional investors had yet to step in.

Click Here – Get Free Investment Predictions

Paras Healthcare IPO Details

The table below sets out the key parameters of the Paras Healthcare IPO.

Open Date 21 October 2026
Close Date 23 October 2026
Face Value Re 1 per share
Price Band Rs 660 to Rs 693 per share
Lot Size 21 shares
Issue Size About Rs 1,450 crore (fresh issue Rs 500 crore, offer for sale Rs 950 crore)
Issue Type Book Built Issue, Mainboard
Listing At BSE, NSE
Allotment Date 26 October 2026
Listing Date 28 October 2026

Paras Healthcare IPO Subscription Status Day 2

The table below tracks how the issue has moved through its bidding window, from the Day 1 close through to the Day 1 reading on Wednesday, 21 October.

Session Overall QIB NII Retail
Day 1 close (21 Oct) 0.15x 0.00x 0.08x 0.73x
Day 2, so far (22 Oct) Updating through the session

With up to 75 percent of the offer reserved for institutions, QIB bids in an issue like this often arrive in the closing hours. Figures are the exchange reading at about 5:07 PM on 21 October, so confirm final numbers on NSE or BSE as bidding continues until 23 October.

Track Subscription Status for the issue on the Univest Screener

How to Apply for the Paras Healthcare IPO

  1. Open a Demat and trading account with a SEBI-registered broker such as Univest if you do not already have one.
  2. Select the issue on your broker app or net banking platform and enter your bid quantity and price within the Rs 660 to Rs 693 band, in multiples of 21 shares.
  3. Submit the application through the UPI-based ASBA method so the bid amount is blocked rather than debited immediately.
  4. Approve the UPI mandate on your phone before the daily cut off time, keeping in mind the issue closes on 23 October.

Download the Univest iOS App or Univest Android App to apply for the issue before the 23 October close.

Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

Conclusion

The issue enters Day 2 at 0.15 times, with retail ahead of NII and QIB. Investors considering the issue should weigh the borrowings on the balance sheet, the planned Gurugram and Ludhiana expansion and the valuation against listed hospital peers, and read the RHP on bseindia.com before applying after independent due diligence.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the Paras Healthcare IPO subscription status on Day 2?

Ans. The issue carries forward a Day 1 close of 0.15 times overall, with retail at 0.73 times, NII at 0.08 times and QIB at 0.00 times, and figures for Day 2, 22 October 2026, are updating through today's session on BSE and NSE.

When does the Paras Healthcare IPO close?

Ans. The issue closes for subscription on 23 October 2026, having opened on 21 October 2026.

What is the Paras Healthcare IPO price band and lot size?

Ans. The issue price band is Rs 660 to Rs 693 per share, with a lot size of 21 shares. A retail investor needs at least one lot, which is about Rs 14,553 at the upper price band.

Is the Paras Healthcare IPO fully subscribed?

Ans. Not yet. The issue was subscribed 0.15 times at the Day 1 reading on 21 October, with retail at 0.73 times, NII at 0.08 times and QIB at 0.00 times excluding the anchor portion.

What is the Paras Healthcare IPO GMP?

Ans. Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

How do I apply for the Paras Healthcare IPO?

Ans. You can apply for the issue through your SEBI-registered broker or UPI-enabled banking app using the ASBA method, enter your bid quantity and price within the Rs 660 to Rs 693 band, in multiples of 21 shares, then approving the UPI mandate before the daily cut off.

When will the Paras Healthcare IPO be allotted and listed?

Ans. The issue allotment is expected to be finalised on 26 October 2026, with listing on BSE and NSE tentatively scheduled for 28 October 2026.

What does Paras Healthcare Limited do?

Ans. Paras Healthcare Limited operates the Paras Health brand of tertiary and quaternary care hospitals in North India, Bihar and Jharkhand, with eight hospitals and 2,211 beds as of 30 June 2026.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down